INHIBITORS OF THE HEDGEHOG PATHWAY

INHIBITORS OF THE HEDGEHOG PATHWAY

INHIBITORS OF THE HEDGEHOG PATHWAYAbstractThe present invention is directed to a compound of Formula (I) or a single isomer thereof; where the compound is optionally as a phamaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RIDGWAY, BRIAN HUGH, BAJJALIEH, WILLIAM, WANG, YONG, TESFAI, ZEROM, HUYNH, TAI PHAT, FORSYTH, TIMOTHY PATRICK, CHEN, JEFF, MANN, GRACE, SHI, XIAN, MAC, MORRISON B, TAKEUCHI, CRAIG STACY, SANGALANG, JOAN C, MARLOWE, CHARLES K, EPSHTEYN, SERGEY, KIM, BYUNG GYU, BAHCECI, SULEYMAN, LEAHY, JAMES W, LEE, MATTHEW SANGYUP, LEWIS, GARY L
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RIDGWAY, BRIAN HUGH
BAJJALIEH, WILLIAM
WANG, YONG
TESFAI, ZEROM
HUYNH, TAI PHAT
FORSYTH, TIMOTHY PATRICK
CHEN, JEFF
MANN, GRACE
SHI, XIAN
MAC, MORRISON B
TAKEUCHI, CRAIG STACY
SANGALANG, JOAN C
MARLOWE, CHARLES K
EPSHTEYN, SERGEY
KIM, BYUNG GYU
BAHCECI, SULEYMAN
LEAHY, JAMES W
LEE, MATTHEW SANGYUP
LEWIS, GARY L
description INHIBITORS OF THE HEDGEHOG PATHWAYAbstractThe present invention is directed to a compound of Formula (I) or a single isomer thereof; where the compound is optionally as a phamaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula 1, and methods of using a Compound of Formula (I) to treat cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG179418A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG179418A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG179418A13</originalsourceid><addsrcrecordid>eNrjZFDy9PPwdPIM8Q8KVvB3UwjxcFXwcHVxd_Xwd1cIcAzxCHeM5GFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8cHuhuaWJoYWjobGhFUAAK0bIZ8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF THE HEDGEHOG PATHWAY</title><source>esp@cenet</source><creator>RIDGWAY, BRIAN HUGH ; BAJJALIEH, WILLIAM ; WANG, YONG ; TESFAI, ZEROM ; HUYNH, TAI PHAT ; FORSYTH, TIMOTHY PATRICK ; CHEN, JEFF ; MANN, GRACE ; SHI, XIAN ; MAC, MORRISON B ; TAKEUCHI, CRAIG STACY ; SANGALANG, JOAN C ; MARLOWE, CHARLES K ; EPSHTEYN, SERGEY ; KIM, BYUNG GYU ; BAHCECI, SULEYMAN ; LEAHY, JAMES W ; LEE, MATTHEW SANGYUP ; LEWIS, GARY L</creator><creatorcontrib>RIDGWAY, BRIAN HUGH ; BAJJALIEH, WILLIAM ; WANG, YONG ; TESFAI, ZEROM ; HUYNH, TAI PHAT ; FORSYTH, TIMOTHY PATRICK ; CHEN, JEFF ; MANN, GRACE ; SHI, XIAN ; MAC, MORRISON B ; TAKEUCHI, CRAIG STACY ; SANGALANG, JOAN C ; MARLOWE, CHARLES K ; EPSHTEYN, SERGEY ; KIM, BYUNG GYU ; BAHCECI, SULEYMAN ; LEAHY, JAMES W ; LEE, MATTHEW SANGYUP ; LEWIS, GARY L</creatorcontrib><description>INHIBITORS OF THE HEDGEHOG PATHWAYAbstractThe present invention is directed to a compound of Formula (I) or a single isomer thereof; where the compound is optionally as a phamaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula 1, and methods of using a Compound of Formula (I) to treat cancer.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120427&amp;DB=EPODOC&amp;CC=SG&amp;NR=179418A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120427&amp;DB=EPODOC&amp;CC=SG&amp;NR=179418A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RIDGWAY, BRIAN HUGH</creatorcontrib><creatorcontrib>BAJJALIEH, WILLIAM</creatorcontrib><creatorcontrib>WANG, YONG</creatorcontrib><creatorcontrib>TESFAI, ZEROM</creatorcontrib><creatorcontrib>HUYNH, TAI PHAT</creatorcontrib><creatorcontrib>FORSYTH, TIMOTHY PATRICK</creatorcontrib><creatorcontrib>CHEN, JEFF</creatorcontrib><creatorcontrib>MANN, GRACE</creatorcontrib><creatorcontrib>SHI, XIAN</creatorcontrib><creatorcontrib>MAC, MORRISON B</creatorcontrib><creatorcontrib>TAKEUCHI, CRAIG STACY</creatorcontrib><creatorcontrib>SANGALANG, JOAN C</creatorcontrib><creatorcontrib>MARLOWE, CHARLES K</creatorcontrib><creatorcontrib>EPSHTEYN, SERGEY</creatorcontrib><creatorcontrib>KIM, BYUNG GYU</creatorcontrib><creatorcontrib>BAHCECI, SULEYMAN</creatorcontrib><creatorcontrib>LEAHY, JAMES W</creatorcontrib><creatorcontrib>LEE, MATTHEW SANGYUP</creatorcontrib><creatorcontrib>LEWIS, GARY L</creatorcontrib><title>INHIBITORS OF THE HEDGEHOG PATHWAY</title><description>INHIBITORS OF THE HEDGEHOG PATHWAYAbstractThe present invention is directed to a compound of Formula (I) or a single isomer thereof; where the compound is optionally as a phamaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula 1, and methods of using a Compound of Formula (I) to treat cancer.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDy9PPwdPIM8Q8KVvB3UwjxcFXwcHVxd_Xwd1cIcAzxCHeM5GFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8cHuhuaWJoYWjobGhFUAAK0bIZ8</recordid><startdate>20120427</startdate><enddate>20120427</enddate><creator>RIDGWAY, BRIAN HUGH</creator><creator>BAJJALIEH, WILLIAM</creator><creator>WANG, YONG</creator><creator>TESFAI, ZEROM</creator><creator>HUYNH, TAI PHAT</creator><creator>FORSYTH, TIMOTHY PATRICK</creator><creator>CHEN, JEFF</creator><creator>MANN, GRACE</creator><creator>SHI, XIAN</creator><creator>MAC, MORRISON B</creator><creator>TAKEUCHI, CRAIG STACY</creator><creator>SANGALANG, JOAN C</creator><creator>MARLOWE, CHARLES K</creator><creator>EPSHTEYN, SERGEY</creator><creator>KIM, BYUNG GYU</creator><creator>BAHCECI, SULEYMAN</creator><creator>LEAHY, JAMES W</creator><creator>LEE, MATTHEW SANGYUP</creator><creator>LEWIS, GARY L</creator><scope>EVB</scope></search><sort><creationdate>20120427</creationdate><title>INHIBITORS OF THE HEDGEHOG PATHWAY</title><author>RIDGWAY, BRIAN HUGH ; BAJJALIEH, WILLIAM ; WANG, YONG ; TESFAI, ZEROM ; HUYNH, TAI PHAT ; FORSYTH, TIMOTHY PATRICK ; CHEN, JEFF ; MANN, GRACE ; SHI, XIAN ; MAC, MORRISON B ; TAKEUCHI, CRAIG STACY ; SANGALANG, JOAN C ; MARLOWE, CHARLES K ; EPSHTEYN, SERGEY ; KIM, BYUNG GYU ; BAHCECI, SULEYMAN ; LEAHY, JAMES W ; LEE, MATTHEW SANGYUP ; LEWIS, GARY L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG179418A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>RIDGWAY, BRIAN HUGH</creatorcontrib><creatorcontrib>BAJJALIEH, WILLIAM</creatorcontrib><creatorcontrib>WANG, YONG</creatorcontrib><creatorcontrib>TESFAI, ZEROM</creatorcontrib><creatorcontrib>HUYNH, TAI PHAT</creatorcontrib><creatorcontrib>FORSYTH, TIMOTHY PATRICK</creatorcontrib><creatorcontrib>CHEN, JEFF</creatorcontrib><creatorcontrib>MANN, GRACE</creatorcontrib><creatorcontrib>SHI, XIAN</creatorcontrib><creatorcontrib>MAC, MORRISON B</creatorcontrib><creatorcontrib>TAKEUCHI, CRAIG STACY</creatorcontrib><creatorcontrib>SANGALANG, JOAN C</creatorcontrib><creatorcontrib>MARLOWE, CHARLES K</creatorcontrib><creatorcontrib>EPSHTEYN, SERGEY</creatorcontrib><creatorcontrib>KIM, BYUNG GYU</creatorcontrib><creatorcontrib>BAHCECI, SULEYMAN</creatorcontrib><creatorcontrib>LEAHY, JAMES W</creatorcontrib><creatorcontrib>LEE, MATTHEW SANGYUP</creatorcontrib><creatorcontrib>LEWIS, GARY L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RIDGWAY, BRIAN HUGH</au><au>BAJJALIEH, WILLIAM</au><au>WANG, YONG</au><au>TESFAI, ZEROM</au><au>HUYNH, TAI PHAT</au><au>FORSYTH, TIMOTHY PATRICK</au><au>CHEN, JEFF</au><au>MANN, GRACE</au><au>SHI, XIAN</au><au>MAC, MORRISON B</au><au>TAKEUCHI, CRAIG STACY</au><au>SANGALANG, JOAN C</au><au>MARLOWE, CHARLES K</au><au>EPSHTEYN, SERGEY</au><au>KIM, BYUNG GYU</au><au>BAHCECI, SULEYMAN</au><au>LEAHY, JAMES W</au><au>LEE, MATTHEW SANGYUP</au><au>LEWIS, GARY L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF THE HEDGEHOG PATHWAY</title><date>2012-04-27</date><risdate>2012</risdate><abstract>INHIBITORS OF THE HEDGEHOG PATHWAYAbstractThe present invention is directed to a compound of Formula (I) or a single isomer thereof; where the compound is optionally as a phamaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula 1, and methods of using a Compound of Formula (I) to treat cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_SG179418A1
source esp@cenet
title INHIBITORS OF THE HEDGEHOG PATHWAY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A13%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RIDGWAY,%20BRIAN%20HUGH&rft.date=2012-04-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG179418A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true